REQUIREMENT OF PHOSPHOLIPASE C-GAMMA-2 ACTIVATION IN SURFACE-IMMUNOGLOBULIN M-INDUCED B-CELL APOPTOSIS

被引:181
作者
TAKATA, M
HOMMA, Y
KUROSAKI, T
机构
[1] AMER CYANAMID CO,LEDERLE LABS,DEPT CARDIOVASC MOLEC BIOL,PEARL RIVER,NY 10965
[2] YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06510
[3] TOKYO METROPOLITAN INST GERONTOL,DEPT BIOSIGNAL RES,ITABASHI KU,TOKYO 173,JAPAN
关键词
D O I
10.1084/jem.182.4.907
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Surface IgM (sIgM) stimulation induces the tyrosine phosphorylation of multiple cellular substrates, including phospholipase C (PLC)-gamma 2, which is involved in the activation of phosphatidylinositol pathway. DT40 B cells underwent apoptotic cell death when activated through sIgM, a phenomenon that is related to elimination of self-reactive B cells. To examine the roles of PLC-gamma 2 in sIgM signaling, we have generated DT40 cells deficient in PLC-gamma 2 Cross-linking of sIgM on PLC-gamma 2-deficient cells evoked neither inositol 1,4,5-trisphosphate nor calcium mobilization. In PLC-gamma 2- or Syk-deficient DT40 cells, the induction of apoptosis was blocked, but was still observed in Lyn-deficient cells. Src homology 2 domains of PLC-gamma 2 were essential for both its activation and sIgM-induced apoptosis. Since tyrosine phosphorylation of PLC-gamma 2 is mediated by Syk, these results indicate that activation of PLC-gamma 2 through Syk is required for sIgM-induced apoptosis.
引用
收藏
页码:907 / 914
页数:8
相关论文
共 84 条
[21]   MUSCARINIC RECEPTOR-OPERATED CA2+ INFLUX IN TRANSFECTED FIBROBLAST CELLS IS INDEPENDENT OF INOSITOL PHOSPHATES AND RELEASE OF INTRACELLULAR CA2+ [J].
FELDER, CC ;
POULTER, MO ;
WESS, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (02) :509-513
[22]   LYMPHOMA MODELS FOR B-CELL ACTIVATION AND TOLERANCE .10. ANTI-MU-MEDIATED GROWTH ARREST AND APOPTOSIS OF MURINE B-CELL LYMPHOMAS IS PREVENTED BY THE STABILIZATION OF MYC [J].
FISCHER, G ;
KENT, SC ;
JOSEPH, L ;
GREEN, DR ;
SCOTT, DW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :221-228
[23]   PREVENTION OF PROGRAMMED CELL-DEATH OF SYMPATHETIC NEURONS BY THE BCL-2 PROTOONCOGENE [J].
GARCIA, I ;
MARTINOU, I ;
TSUJIMOTO, Y ;
MARTINOU, JC .
SCIENCE, 1992, 258 (5080) :302-304
[24]  
GILLILAND LK, 1992, J BIOL CHEM, V267, P13610
[25]  
GOLD MR, 1994, ADV IMMUNOL, V55, P221
[26]  
GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421
[27]  
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
[28]  
HASBOLD J, 1990, EUR J IMMUNOL, V220, P1685
[29]  
HEMPEL WM, 1992, J IMMUNOL, V148, P3021
[30]  
HEMPEL WM, 1991, J IMMUNOL, V146, P3713